Stay updated on ASG-22CE Dose Escalation in Nectin-4+ Tumors Clinical Trial

Sign up to get notified when there's something new on the ASG-22CE Dose Escalation in Nectin-4+ Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the ASG-22CE Dose Escalation in Nectin-4+ Tumors Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    The study page now shows a 403 Forbidden message, replacing the usual content, and the Home link appears to be removed, indicating restricted access to the page.
    Difference
    0.5%
    Check dated 2026-09-28T22:38:17.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    The study record page now displays a 403 Forbidden error, replacing the previous content with an error screen and signaling restricted access to the record.
    Difference
    20%
    Check dated 2026-09-21T22:28:45.000Z thumbnail image
  4. Check
    41 days ago
    Change Detected
    Summary
    The page’s revision stamp was updated to v3.6.6, signaling a new version of the page. This appears to be a routine update rather than a substantive change to the trial details or user-facing information.
    Difference
    0.0%
    Check dated 2026-08-31T17:19:36.000Z thumbnail image
  5. Check
    62 days ago
    Change Detected
    Summary
    A new site revision marker 'Revision: v3.6.5' is displayed, and the link to the plain language summary of the study on the Trial Results Summaries site has been removed.
    Difference
    0.1%
    Check dated 2026-08-10T13:24:52.000Z thumbnail image
  6. Check
    76 days ago
    Change Detected
    Summary
    The page revision has been updated to v3.6.4, replacing the previous v3.6.3, indicating a small update to the page’s underlying version rather than substantive content changes.
    Difference
    0.0%
    Check dated 2026-07-27T06:23:05.000Z thumbnail image
  7. Check
    83 days ago
    Change Detected
    Summary
    Added a statement that anonymized individual participant data will not be provided for this trial and directed readers to the data sharing policy. Previous IPD sharing links and related information were removed.
    Difference
    0.7%
    Check dated 2026-07-20T01:09:48.000Z thumbnail image

Stay in the know with updates to ASG-22CE Dose Escalation in Nectin-4+ Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the ASG-22CE Dose Escalation in Nectin-4+ Tumors Clinical Trial page.